Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Faster Ambulance Transport System for People Having a Stroke

Tests a new ambulance system to speed treatment for adults with acute ischemic stroke.

Plain-language title generated from the registry record
Registry title: Prehospital Response and Emergency Stroke Transport Optimisation

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Xuanwu Hospital, Beijing
Trial code
NCT07892053
Record updated
23 October 2026
Original description
This study aims to develop and evaluate an innovative prehospital emergency transport system for patients with acute ischemic stroke to reduce delays in reperfusion treatment. The system integrates artificial intelligence-based prehospital stroke assessment, selected examinations and blood collection in the ambulance, and real-time information sharing between emergency medical services and the receiving hospital. Its effectiveness will be evaluated in a multicenter, stepped-wedge cluster randomized controlled trial comparing the innovative system with standard prehospital care. The primary outcome is the time from hospital arrival to intravenous thrombolysis.Read full original descriptionShow less

Prehospital Response and Emergency Stroke Transport Optimisation: A Multicentre, Stepped-Wedge Cluster-Randomized Clinical Trial

This study aims to develop and evaluate an innovative prehospital emergency transport system for patients with acute ischemic stroke to reduce delays in reperfusion treatment. The system integrates artificial intelligence-based prehospital stroke assessment, selected examinations and blood collection in the ambulance, and real-time information sharing between emergency medical services and the receiving hospital. Its effectiveness will be evaluated in a multicenter, stepped-wedge cluster randomized controlled trial comparing the innovative system with standard prehospital care. The primary outcome is the time from hospital arrival to intravenous thrombolysis.

Inclusion: Hospitals:; Hospitals with thrombolysis qualification and equipped with ambulances and pre-hospital emergency personnel; Pre-hospital emergency care can apply the AI-based innovative pre-hospital transport system; The hospital receives at least 60 stroke patients transferred via pre-hospital emergency and receiving intravenous thrombolysis annually; Patients:; Age ≥ 18 years; Suspected acute ischemic stroke patients; Symptom onset ≤ 4.5 hours; Arrival at the hospital via the pre-hospital emergency transport system; Signed informed consent.

Exclusion: Hospitals participating in other research projects aimed at improving pre-hospital emergency processes or stroke thrombolysis treatment; Patients:; Hospitals:; Patients who arrive at the hospital spontaneously (self-presentation); Patients deemed unsuitable for inclusion in the clinical trial by the investigators.

ClinicalTrials.gov NCT07892053